As a result of increasing R&D initiatives in cancer treatment, providers and patients are being wooed with a multitude of choices. However, this has stoked several complexities in treatment options. Both groups are reeling under the possibility of increased progression fee. Besides this, the rising willingness of patients to spend on advanced treatment options, prevalence of unmet needs, and a bulging pipeline of novel drugs are some of the factors which will exert considerable influence on the oncology drugs department.

Through our extensively researched reports, we offer updated perspective on some of the most crucial trends prevailing in this sector. Our observations cover novel treatments, availability of cures, costs incurred in oncology medications and associated drugs, distribution channel, and other related factors, which are crucial to chalk a positive trajectory in the oncology drugs market.

Oncology Drugs
Prostate Cancer Therapeutics Market (Therapy- Hormone Therapy (Luteizing Hormone - Releasing Hormone Analogs, Luteinizing Hormone - Releasing Hormone Antagonists, and Anti-androgens), Chemotherapy (Systemic Therapy and Regional Chemotherapy), Biologic Therapy, and Targeted Therapy; Distribution Channel - Hospital Pharmacy, Retail Pharmacy, and Online sales) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2024

Mar, 2018 | 171 pages

This report on the prostate cancer therapeutics market examines past and current scenario to present projections at both regional and global level. The global prostate cancer therapeutics market study includes an extensive executive summary, comprising market snapshot that provides information about key segments.

Oncology Drugs
Basal Cell Carcinoma Treatment Market (Treatment type - Surgical (Surgical Excision, Electrodessication & Cutterage, Moh's Surgery, and Cryosurgery), Drugs (Topical Treatment, Advanced Medication, and Other), and Others (Radiation Therapy, Photodynamic Therapy, and Laser Therapy); End-users- Hospitals, Specialty Clinics, and Others: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017 - 2025

Feb, 2018 | 165 pages

This report on the global basal cell carcinoma treatment market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments. The research is a combination of primary and secondary research. Primary research formed the bulk of our research efforts along with information collected from telephonic interviews and interactions via e-mails. 

Oncology Drugs
Anticancer Drugs Market (Drug Type - Cytotoxic Drugs (Alkylating Agents, and Antimetabolites), Targeted Drugs (Monoclonal Antibodies and Tyrosine Kinase Inhibitors), and Hormonal Drugs; Therapy Type - Chemotherapy, Targeted Therapy, and Immunotherapy; Cancer Type - Lung Cancer, Breast Cancer, Leukemia, and Colorectal Cancer) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Jan, 2018 | 226 pages

This report on the global anticancer drugs market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments.

Oncology Drugs
Pneumococcal Vaccines Market (Product Type– 7- Valent PCV, 10- Valent PCV, 13- Valent PCV, 23- Valent PPSV; Distribution Channel - Hospitals, Clinics, Other Distribution Channels) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2026 Featured

Dec, 2017 | 170 pages

The prevention of disease through vaccination is one of the most cost-effective and safe ways. Pneumococcus is one of the leading causes of blood infection, pneumonia, sinusitis, meningitis, and otitis media.

Oncology Drugs
Chronic Myelogenous Leukemia Treatment Market (Treatment Type - Disease Specific Treatment, Symptomatic Treatment; Distribution Channel - Hospital Pharmacies, Specialty Pharmacies, Retail Pharmacies; Drug Type- Branded, Generic) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2026 Featured

Nov, 2017 | 170 pages

Chronic Myelogenous Leukemia (CML) takes place when the bone marrow starts making too many white blood cells. This may affect red blood cells, white blood cells, and platelets. The first line treatment for CML in chronic phase is being largely treated with targeted drugs such as tyrosine kinase inhibitors (TKIs) nilotinib (Tasigna) and dasatinib (Sprycel).

Oncology Drugs
Rare Hematology Market (Product Type - Plasma Derived Factors, Recombinant Factors, Hemophilia A, Hemophilia B, Von Wilebrand Disease, Acquired Hemophilia A, Others; Age -Adult and Pediatric) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2022 Featured

Nov, 2017 | 170 pages

The global rare hematology market is expected to witness a healthy growth attributed to growing prevalence of blood related disorders. Surge in demand to conduct the diagnosis process at the early phase is expected to impact growth of the global rare hematology market significantly.

Oncology Drugs
Oncology Biosimilars Market (Drug Class - G-CSF, Monoclonal Antibodies, and Hematopoietic Agents; Disease Indication - Breast Cancer, Non-small Cell Lung Cancer, Colorectal Cancer, Neutropenia, and Blood Cancer (Leukemia and Non-Hodgkin Lymphoma); and Distribution Channel - Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Sep, 2017 | 183 pages

The market for oncology biosimilars has just a few players and hence is consolidated in nature. Big shot players in the market are seen forging carefully-considered collaborations to expand their geographical footprints. A case in point is Dr. Reddy’s Laboratories, which entered into an agreement with TR-Pharm to strengthen its presence in the Middle East. According to the deal, TR-Pharm is required to commercialize Dr. Reddy’s three biosimilars in Turkey.

Oncology Drugs
Monoclonal Antibody Therapeutics Market (Application - Cancer, Autoimmune Diseases, Infection, Hematological Diseases, Ophthalmological Diseases, and Others; Source - Human, Humanized, Chimeric, and Others; End User - Hospitals, Private Clinic and Research Institute) - Global Industry Analysis, Size, Share, Volume, Growth, Trends, and Forecast 2016 - 2024

Jan, 2017 | 185 pages

Monoclonal antibodies are a type of biological therapy used in the treatment serious conditions such as cancer, rheumatoid arthritis, Crohn’s diseases, psoriasis, osteoporosis, systemic lupus erythematous, and others. Monoclonal antibody are target specific in action by not affect the other cells of the body thus restores the immune system.

Oncology Drugs
Cancer Immunotherapy Market (Therapy Type - Monoclonal Antibodies, Immune Checkpoint Inhibitors (PD-1/PD-L1 and CTLA-4), Immune System Modulators, and Cancer Vaccines; Therapeutic Areas - Lung Cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer, Melanoma, and Blood Cancers; End Users - Hospitals, ASC’s (Ambulatory Surgical Centers), and Cancer Research Centers) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Dec, 2016 | 222 pages

The growing incidences of cancer and a need to treat them is the key driver of the global immunotherapy market. The number of deaths occurring due to cancer is increasing every year and has therefore forced government bodies to take initiatives for the improvement of the health conditions of people, by investing heavily in research and development and enabling innovation and advancements in technology so as to offer improved treatments. 

Oncology Drugs
Breast Cancer Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024

Nov, 2015 | 88 pages

Changes in lifestyle and obesity are some of the key risk factors causing breast cancer. The incidence of the disease is more prevalent in women than in men, and is aggravated by the presence of several co-morbidity factors, with no clear causes. According to Breastcancer.org, a non-profit organization working on the diagnosis, treatment, and management of the disease, about one in eight women in the U.S. is likely to develop invasive breast cancer over the lifetime span.

Oncology Drugs
Circulating Tumor Cells (CTCs) Prognostic Technologies Market - Technologies: Tumor Cell Enrichment (Filtration, Centrifugation and Immunological & Immunomagnetic Methods) & Tumor Cell Detection (Molecular Methods and Optical Methods) and Applications: Prostate Cancer, Breast Cancer, Colorectal Cancer and Others - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020

Jun, 2014 | 100 pages

This report provides the market analysis for various technologies and applications used for the enrichment and detection of circulating tumor cells (CTCs). The stakeholders of this report include companies and research institutes involved in the production of prognosis kits and research and development activities related to circulating tumor cells technologies as well as the new entrants who wish to enter this market.

.